You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Characteristics of people treated for localised melanoma by follow-up practice patternsa

From: Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma

  All follow-up with MIA or included follow-up with specialist outside MIA (n = 122) Follow-up outside MIA which included local GP (n = 100) Comparison of follow-up which did and did not include local GP (p-value)b Total (n = 230)c
Age in years, mean (SD) 62.9 (14.3) 62.6 (11.9) 0.81 62.6 (13.2)
Gender    0.006  
 Female 47 (39, 56) 30 (22, 39)   38 (33, 44)
 Male 53 (45, 61) 70 (61, 78)   62 (56, 67)
Living with others 77 (69, 84) 77 (68, 84) 0.95 78 (72, 83)
Highest educational level    < 0.001  
 Did not complete secondary school 15 (10, 22) 38 (29, 47)   26 (21, 32)
 Completed secondary school 31 (24, 39) 14 (9, 21)   24 (19, 29)
 Completed certificate or trade 27 (21, 35) 28 (20, 37)   27 (22, 32)
 Completed university degree 27 (20, 35) 21 (14, 29)   24 (19, 29)
Missing     (n = 1)
SEIFA categoryd    0.34  
 Low socio-economic status (deciles 1–3) 15 (10, 22) 20 (13, 28)   18 (13, 23)
 Medium to High socio-economic status (deciles 4–10) 85 (78, 90) 80 (72, 87)   83 (77, 87)
Remoteness areae    < 0.001*  
 Major cities of Australia 83 (76, 88) 66 (57, 75)   75 (69, 80)
 Inner regional Australia 15 (10, 22) 26 (19, 34)   19 (15, 25)
 Outer regional Australia 2 (1, 3) 8 (4, 15)   6 (4, 9)
Age at diagnosis in years, mean (SD) 60.9 (14.4) 60.8 (11.9) 0.85 60.7 (13.3)
More than a year since diagnosis 90 (84, 94) 92 (85, 96) 0.55 91 (87, 94)
AJCC substage    0.02*  
 Stage 0 20 (14, 28) 25 (18, 35)   23 (18, 29)
 Stage IA 20 (14, 28) 28 (20, 38)   25 (20, 31)
 Stage IB 38 (30, 47) 30 (22, 39)   33 (27, 39)
 Stage IIA 11 (9, 13) 10 (8, 12)   11 (10, 12)
 Stage IIB/C 11 (9, 13) 7 (6, 9)   9 (8, 10)
Primary site of melanoma    0.15  
 Limb 51 (42, 59) 38 (30, 48)   46 (40, 52)
 Trunk 30 (23, 38) 37 (29, 46)   33 (27, 39)
 Head or neck 20 (14, 27) 24 (17, 33)   22 (17, 27)
History of non-melanoma skin cancer (NMSC) 46 (38, 54) 59 (49, 67) 0.08 50 (44, 56)
Other chronic health problem 21 (15, 28) 26 (19, 35) 0.35 23 (18, 28)
No. of different doctors seen last year for skin checks    < 0.001*  
 0 0 0   4 (2, 7)
 1 56 (47, 64) 28 (21, 38)   41 (36, 47)
 2 35 (27, 43) 41 (33, 50)   36 (31, 42)
 3 10 (6, 15) 31 (23, 40)   19 (15, 24)
  1. AJCC American Joint Committee on Cancer, GP general practitioner, MIA Melanoma Institute Australia, SD standard deviation, SEIFA Socio-Economic Indexes For Areas
  2. *Trend test
  3. aAll values reported are column percentages (95% confidence intervals) unless otherwise indicated. Percentages were adjusted for stratified sampling from the total inception cohort. Some column totals do not add to 100% due to rounding
  4. bp-values for comparison of [all follow-up with MIA + follow-up outside MIA not including GP] group versus follow-up outside MIA including GP group
  5. cIncluded people who had no follow-up in the past year (n = 8)
  6. dBased on Postal Area Index of Relative Socio-Economic Advantage and Disadvantage, Australian Bureau of Statistics 2011 [32]
  7. eBased on 1270055006C190 Postcode 2012 to Remoteness Area 2011, Australian Bureau of Statistics 2011 [33]